Recent reports have shown that the administration of IL-15 with its soluble receptor IL-15Rα complex enhanced the bioavailability of IL-15 by about 50-fold and showed elevated tumor-eliminating effects in vivo [14, 15]. Here, IL15 is linked to neoplasm.